Ann Kalita

Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically

Miranda Thomas, A. Kalita, S. Labrecque, 1999, Molecular and Cellular Biology.

Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.

Isabelle Paquin, Daniel Delorme, A. Kalita, 2008, Journal of medicinal chemistry.

Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer

Irene M. Leigh, Catherine A. Harwood, Judith Breuer, 1998, Nature.

MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo

Sylvain Lefebvre, Daniel Delorme, A. Kalita, 2008, Molecular Cancer Therapeutics.

Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors.

Daniel Delorme, A. Kalita, M. Robert, 2003, Journal of medicinal chemistry.